Journal of Biological Chemistry · 2012 · 41 citations · 38 references
MedicineMolecular BiologyOncologyChromatin BiologyMolecular OncologyOncogenesCancer Cell SignalingCancer EpigeneticsEpigenetic Regulation In CancerHistone ProteinsMalignant NeoplasmsSignal Transduction In CancerHer2 ExpressionHer2 Receptor SignalingHuman Epidermal Growth Factor Receptor 2 (Her2) Expression
Because HER-2 has been demonstrated in the nuclei of cancer cells, we hypothesized that it might interact with transcription factors that activate ERBB2 transcription. Macrohistone 2A1 ( H2AFY ; mH2A1) was found to interact with HER-2 in cancer cells that overexpress HER-2. Of the two human mH2A1 isoforms, mH2A1.2, but not mH2A1.1, interacted with HER-2 in human cancer cell lines. Overexpression of mH2A1.2, but not mH2A1.1, in cancer cells significantly increased HER-2 expression and tumorigenicity. Inhibition of HER-2 kinase activity diminished mH2A1 expression and mH2A1.2-induced ERBB2 transcription in cancer cells. Chromatin immunoprecipitation of mH2A1.2 in cancer cells stably transfected with mH2A1.2 showed enrichment of mH2A1.2 at the HER-2 promoter, suggesting a role for mH2A1.2 in driving HER-2 overexpression. The evolutionarily conserved macro domain of mH2A1.2 was sufficient for the interaction between HER-2 and mH2A1.2 and for mH2A1.2-induced ERBB2 transcription. Within the macro domain of mH2A1.2, a trinucleotide insertion (-EIS-) sequence not found in mH2A1.1 was essential for the interaction between HER-2 and mH2A1.2 as well as mH2A1.2-induced HER-2 expression and cell proliferation. Background: HER-2/c-erbB-2 is commonly overexpressed in cancers, but how its overexpression is achieved is not well understood. Results: HER-2 was found to interact with the atypical histone macroH2A1.2. Conclusion: HER-2 cooperates with macroH2A1.2 to drive HER-2 overexpression in cancer cells. Significance: The discovery of a novel interaction between mH2A1.2 and HER-2 reveals a unique mechanism by which oncogenes can broadly deregulate gene transcription in cancer cells.
38
Concordance among Gene-Expression–Based Predictors for Breast Cancer
Daniel Oh, Lodewyk F.A. Wessels, Britta Weigelt et al. · New England Journal of Medicine · 2006 · 1.3K citations · Full text
Medicine, Cancer Biology, Oncology +17
X chromosomal abnormalities in basal-like human breast cancer
Andrea L. Richardson, Zhigang C. Wang, Arcangela De Nicolo et al. · Cancer Cell · 2006 · 885 citations · Full text
Life Sciences, Genetics, Oncology +14